- Sanofi Pasteur's (NASDAQ:SNY) quadrivalent vaccine VaxigripTetra receives a positive end-of-procedure from Germany's Paul Ehrlich Institute clearing the way for a Marketing Authorization there as the Reference Member State per the European Decentralized Procedure. Marketing approvals can also be issued in other countries, called Concerned Member States, involved in the procedure.
- VaxigripTetra is a four strain influenza vaccine containing two A strains (A/H1N1 and A/H3N2) and two B strains (B/Victoria and B/Yamagata), for use in people at least three years old.